Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With Schizophrenia

L

Ludwig Maximilian University of Munich

Status

Completed

Conditions

Schizophrenia

Treatments

Device: eldith DC-stimulator (neuroconn, Ilmenau, Germany)
Device: eldith DC-stimulator (Neuroconn, Ilmenau, Germany)

Study type

Interventional

Funder types

Other

Identifiers

NCT01378078
04/2011

Details and patient eligibility

About

Transcranial direct current stimulation (tDCS) showed beneficial effects on cognition in healthy subjects and depressed patients. In this study, patients with treatment resistant negative syndrome in schizophrenia will be treated with direct current stimulation. fMRI measures will be performed.

Enrollment

20 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

schizophrenic patients with a negative syndrome. PANSS > 40.

Exclusion criteria

other psychiatric or neurologic diseases.

Trial design

20 participants in 2 patient groups

sham
Sham Comparator group
Description:
patients receive sham tDCS stimulation
Treatment:
Device: eldith DC-stimulator (neuroconn, Ilmenau, Germany)
active
Active Comparator group
Description:
active transcranial direct current stimulation
Treatment:
Device: eldith DC-stimulator (Neuroconn, Ilmenau, Germany)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems